This fact sheet outlines that herpes simplex virus (HSV‑1 and HSV‑2) is a common, lifelong infection causing oral or genital blisters, transmitted via skin-to-skin or saliva contact—even when asymptomatic—and managed through antiviral treatment and preventive measures. It emphasizes that many individuals are unaware of their infection and underscores the role of condoms and suppressive therapy in reducing symptom recurrence and transmission.

This information sheet outlines how individuals can take a two‑pill (200 mg) dose of doxycycline within 24–72 hours after condomless oral, anal, or vaginal sex to significantly reduce the risk of syphilis, gonorrhea, and chlamydia. It provides clear dosing instructions, timing guidance, and encourages regular STI screening and care coordination.

This report describes a newborn diagnosed with congenital syphilis, born to an adolescent mother without routine prenatal care. Despite initial diagnostic challenges, timely testing and treatment led to a positive outcome in accordance with national guidelines.

This brochure highlights the risks of congenital syphilis—such as stillbirth, early birth, or long-term health

This pocket card offers clear, easy-to-understand information on syphilis—including transmission, symptoms, diagnosis, and treatment (penicillin or alternatives for those allergic)—and emphasizes timely testing, partner notification, and prevention strategies like condom use and doxy PEP. It also directs readers to MetroHealth infectious disease specialists for appointments and further support

This toolkit delivers updated data visualizations, infographics, and social media assets spotlighting the intersection of viral hepatitis and the opioid crisis—highlighting regional opioid prescribing rates alongside Hepatitis C mortality trends to support awareness campaigns during Hepatitis Awareness Month.

This guideline provides comprehensive, evidence-based recommendations on prophylaxis, treatment, immunization, and drug interactions for a wide range of pediatric OIs—including new additions for coccidioidomycosis, hepatitis B revaccination, and updated immunization schedules—to guide clinicians caring for HIV‑exposed and infected children.

This guideline offers updated, evidence-based recommendations—from preconception through postpartum—on universal prenatal HIV testing, preferred antiretroviral regimens (e.g., bictegravir/TAF/FTC), maternal viral monitoring, obstetric management, and neonatal prophylaxis to further reduce perinatal HIV transmission toward elimination goals (defined as <1% transmission rate and <1 infection per 100,000 live births).

This information sheet offers an in-depth analysis of current AFP models—including funding mechanisms, stakeholder roles, and implementation strategies—to support sustainability of HIV-related services beyond traditional grant funding. It outlines key considerations and best practices to help health departments and community partners explore and launch innovative financing options for long-term epidemic response planning.